We therefore compared coronary and aortic vascular responses to endothelium-derived vasodilators and exogenous nitric oxide (NO) in three commonly used mouse strains and correlated these data with expression of eNOS, NADPH oxidase subunits, gp91 phox and p67 phox , and superoxide production. Isolated perfused hearts from MF1, 129sv and C57BL/6J mice were subjected to: (a) increasing doses of bradykinin, acetylcholine and sodium nitroprusside, and (b) bolus doses of adenosine and the NO synthase inhibitor, N G -monomethyl-L-arginine. Vascular responses of thoracic aortic rings were assessed for comparison. Expression of eNOS and NADPH oxidase subunits was assessed by immunoblotting, and superoxide production by lucigenin-enhanced chemiluminescence. Coronary vasodilator responses to bradykinin, acetylcholine and sodium nitroprusside were signi®cantly attenuated in MF1 compared with C57BL/6J and 129sv hearts. Similarly, aortic relaxation to acetylcholine was signi®cantly impaired in MF1 aortic rings compared with in C57BL/6J aortae; these differences were reversed by Tiron. N G -monomethyl-L-arginine induced significantly less vasoconstriction in MF1 and 129sv hearts compared with C57BL/6J. No differences in aortic relaxation to A23187 or sodium nitroprusside were observed. Cardiac and aortic superoxide production and cardiac expression of p67 phox and gp91 phox were signi®cantly greater in MF1 mice compared with the other strains. There is signi®cant strain-dependent variation in coronary and aortic vascular responsiveness in mice, which may re¯ect differences in the balance between NO and superoxide generation. # 2002 Published by Elsevier Science Ltd.
Introduction
Recent progress in the ability to manipulate the mammalian genome has led to the proliferation of genetically altered models of disease. As such, genetically modi®ed mice are increasing being used as experimental models of cardiovascular disease. A major strength of this approach is that it uses a precise genetic alteration to investigate complex regulatory processes within the cardiovascular system. However, the molecular techniques requisite for generating such animals developed more rapidly than the methods for studying physiological phenotype. 1 Therefore, only very limited information exists on baseline murine vascular physiology or on potential variations between different murine strains.
Numerous studies in the literature have employed gene-modi®ed mice to investigate vascular, and more speci®cally, endothelial function. 2±4 For example, in contrast to pharmacological modulation via N G -monomethyl-L-arginine, this approach allows the selective inhibition of single isoforms of nitric oxide 1 synthase (NOS) to be studied.
5±6
Knowledge of inherent variations in vascular physiology between different murine strains is therefore essential for accurate data interpretation. Thus, the aim of this study was to assess normal coronary vascular responses to endothelium-dependent vasoactive agonists and exogenous NO in the isolated, perfused heart of three different mouse strains. Vascular responses in aortic rings were studied for comparison. Only one previous study has examined coronary vascular responses in the whole mouse heart 7 although vascular responsiveness to endothelium-dependent and -independent agonists has been studied in mouse aortic rings. 3, 4, 8, 9 None of these studies, however, compared vascular responsiveness between different mouse strains. We studied two inbred strains commonly used for the creation of genetically altered mice in vascular studies, namely C57BL/6J 10±11 and 129sv mice, 12±13 and one outbred strain, the MF1 mouse. Differences in coronary and aortic vascular responses were correlated with differences in (a) expression of endothelial nitric oxide synthase (eNOS), (b) expression of subunits of the major vascular superoxide (O 
Methods
All procedures were performed in accordance with the Guidance on the Operation of Animals (Scienti®c Procedures) Act, 1986 (Her Majesty's Stationery Of®ce, London, UK).
Isolated langendorff-perfused hearts
Adult male C57BL/6J, 129sv and MF1 mice (n ! 6 per group; 8±10 weeks old; Harlan, UK) were anaesthetised (pentobarbital sodium, 0.1 ml/100 g) and heparinised (heparin sodium, 100 IU/100 g) by intraperitoneal injection. Hearts were rapidly excised, cannulated via the aorta, and perfused in non-recirculating Langendorff mode at constant¯o w with Krebs±Henseleit buffer (KHB) containing (in mmol/L) NaCl 116, KCl 4.6, MgSO 4 1.1, NaHCO 3 24.9, CaCl 2 2.5, KH 2 PO 4 1.2, glucose 10, and EDTA 0.5 equilibrated with 95% O 2 and 5% CO 2 (pH 7.4, 37 C). During a 20-min equilibration period, coronary¯ow was adjusted to achieve a coronary perfusion pressure (CPP) of 60 AE 5 mmHg as used previously. 7 A CPP of 60 mmHg was found to produce optimal vasodilator responses and preliminary experiments demonstrated that left ventricular (LV) function was normal at this level. CPP was measured via a pressure transducer and data recorded on a MacLab/8 s system (ADI, Australia). A LV balloon was not used as, in preliminary experiments, it was found to impair vasodilator responses in a signi®cant proportion of animals from each strain thereby introducing additional variability and confounding interpretation of the data.
Bolus doses (10 ml) of the endothelium-dependent vasoactive agents, bradykinin (1 nmol/L±100 mmol/L) and acetylcholine (ACh, 1 nmol/L±10 mmol/L), the endothelium-independent NO agonist, sodium nitroprusside (SNP, 10 nmol/L±1 mmol/L), and adenosine (1 mmol/L) were injected just above the aortic cannula into the coronary¯ow ($1% of the¯ow causing no change in CPP), with suf®cient time allowed between agents to allow recovery of basal CPP. Basal production of NO was estimated as the maximal vasoconstrictor response to N G -monomethyl-L-arginine (L-NMMA, 0.1 mmol/L).
Isolated aortic rings
To assess vascular relaxation independently of confounding factors such as coronary vascular resistance and coronary¯ow, thoracic aortae were studied from C57BL/6J and MF1 mice. Aortae were excised and placed in ice-cold KHB, cleaned of excess adventitial tissue, and cut into 5 mm ring segments. Care was taken not to damage the endothelium. Aortic segments were suspended in individual organ chambers ®lled with KHB (10 ml), continually gassed with 95% O 2 and 5% CO 2 and maintained at 37 C. Tension was recorded with a linear force transducer. The resting tension of the rings was set to 3.0 g. After 40 min equilibration, cumulative dose-response curves to phenylephrine (PE) were performed (1 nmol/L±3 mmol/L) and the concentration of PE required to produce 70% of the maximal contraction used. After a stable contraction plateau was reached, cumulative doseresponse curves to ACh (3 nmol/L±3 mmol/L), the calcium ionophore A23187 (1 nmol/L±0.3 mmol/L) and SNP (1 nmol/L±0.3 mmol/L) were performed. Experiments were also conducted to assess AChinduced relaxation in the presence of the O À 2 scavenger, Tiron (5 mmol/L). Relaxation is expressed as a percentage of the 70% contraction to PE.
Western analyses
LV tissue from C57BL/6J, 129sv and MF1 mice was excised, snap frozen, and stored at À80 C. Tissues were homogenized in buffer containing (in mmol/L) Tris 50 (pH 7.4), NaCl 100, NaF 50, NaEDTA 5, b-glycerophosphate 40, and sodium orthovanadate 0.2. Homogenates were centrifuged to remove insoluble material, and protein concentrations assayed using the Bradford technique.
14 Forty mg protein was loaded onto 10±20% SDS polyacrylamide gels, electrophoresed, and transferred to nitrocellulose membranes (Amersham, UK). For eNOS expression, a 1:2500 dilution of primary mouse anti-eNOS monoclonal antibody (Transduction Laboratories, UK) was used. Monoclonal antibodies (1:1000) against gp91 phox (donated by Dr M. Quinn) and p67 phox (Transduction Laboratories, UK) were employed to assess expression of these NADPH oxidase subunits. Protein bands were detected by the ECL system (Amersham, UK) and visualised by autoradiography. Blots were quanti®ed by densitometry.
Lucigenin-enhanced chemiluminescence
was measured by lucigeninenhanced chemiluminescence according to previously described and validated methods. 15±16 In brief, frozen LV samples from each mouse strain (n ! 5 per group) were homogenized in lysis buffer containing protease inhibitors (1:20, protease cocktail), monobasic potassium phosphate (20 mmol/L) and EGTA (1 mmol/L), pH 7.0. For each sample, tissue homogenate containing 100 mg was added to wells, on a 96-well microplate luminometer (Lucy 1, Rosys Anthos, Austria). The assay buffer comprised of (in mmol/L); sucrose 150, monobasic potassium phosphate 50, and EGTA 1. Immediately before measurement of chemiluminescence, NADPH (300 mmol/L, pH 7.0) was added to each well, followed by dark-adapted lucigenin (5 mmol/L). Chemiluminescence was recorded every minute for 25 min. In some experiments, the cell-permeable O À 2 scavenger 4,5-dihydroxy-1, 3-benzenedisulfonic acid disodium (Tiron, 20 mmol/L), the NOS inhibitor, No-nitro-L-arginine methyl ester hydrochloride (L-NAME, 100 mmol/L), or a¯a voprotein inhibitor diphenyleneiodonium (DPI, 10 mmol/L) were incubated with the homogenate for 5 min before addition of NADPH and lucigenin. A buffer blank (,2% of the homogenate signal) was subtracted from each reading before analysis of the data.
NADPH-driven O À 2 production was also measured in aortic homogenates from MF1 and C57BL/6J mice according to the protocol described above with slight modi®cations; aortae were homogenised (10% weight for volume in lysis buffer) using a glass-glass homogeniser and 10 ml of homogenate was added to each well.
Drugs and chemicals
N G -monomethyl-L-arginine was obtained from Calbiochem (UK); No(-nitro-L-arginine methyl ester hydrochloride, diphenyleneiodium chloride, 4,5-dihydroxy-1,3-benzene-disulfonic acid disodium, NADPH, lucigenin, bradykinin, acetylcholine chloride, adenosine, sodium nitroprusside, L-phenylephrine hydrochloride, calcium ionophore A23187 and protease cocktail from Sigma-Aldrich (UK); and all other chemicals from Merck (BDH) and Laboratory Supplies (UK) unless otherwise stated in the text. All drugs were freshly prepared on the day of the experiment in de-ionised water, except for A23187 which was dissolved in dimethyl sulphoxide (DMSO). DMSO had no effect on vessel function alone at the maximal concentration (0.01%) used in the isolated aortic rings.
Statistics
Data are presented as mean values AE SEM. Doseresponse curves for coronary vasodilator responses and curves for O À 2 production were compared by two-way ANOVA for repeated measures followed by the Fischer's Least Signi®cance post-hoc test. Other data were compared by one-way ANOVA followed by Fischer's Least Signi®cance post-hoc test or by the Student's unpaired t-test. P , 0.05 was considered signi®cant.
Results

Baseline characteristics
Heart weights were similar in all three murine strains (C57BL/6J, 149 AE 9 mg; 129sv, 144 AE 6 mg; MF1, 149 AE 9 mg). However, at the same CPP of 60 mmHg, baseline coronary¯ow in C57BL/6J and 129sv hearts was signi®cantly lower than in MF1 hearts (0.009, 0.012 and 0.017 ml/min/mg respectively, P , 0.001). Consequently, mean coronary vascular resistance was signi®cantly higher in C57BL/6J hearts (43.13 AE 3.42 mmHg/ml/min) compared with MF1 hearts (25.61 AE 1.63 mmHg/ ml/min, P , 0.001), with 129sv hearts being at an intermediate level (33.92 AE 4.81 mmHg/ml/min).
Coronary vasomotor responses
Bradykinin induced signi®cantly greater relaxation in C57BL/6J and 129sv hearts compared with MF1 mice [ Fig. 1(A) ]. Maximal relaxation to bradykinin was 29.4 AE 5.5% and 31.4 AE 5.2% in 129sv and C57BL/6J hearts respectively compared with only 11.5 AE 2.6% for MF1 hearts (P , 0.01).
Relaxation to ACh was also markedly different between the three murine strains. Maximal relaxation to ACh was greatest in C57BL/6J hearts (38.8 AE 5.7%) followed by 129sv (25.5 AE 7.7%) and MF1 (4.9 AE 1.4%) hearts [P , 0.01, Fig. 1(B) ].
In line with these results, coronary relaxation to SNP was also signi®cantly different between the groups. Relaxation in 129sv hearts was signi®cant-ly greater than in MF1 hearts [ Fig. 1(C) ]. Relaxation in C57BL/6J hearts tended to be greater but did not reach signi®cance.
Similarly, maximal vasodilator responses to adenosine were markedly attenuated in MF1 hearts compared with 129sv and C57BL/6J mice [ Fig. 2(A) ; P , 0.01]. L-NMMA increased CPP in hearts in all strains. However, the maximal response was signi®-cantly lower in MF1 and 129sv hearts compared with C57BL/6J hearts [ Fig. 2(B) ; P , 0.01].
Aortic relaxation
To eliminate potential confounding factors such as coronary vascular resistance and coronary¯ow, vascular relaxation was also assessed in aortic rings. In addition, the lack of a preload in the isolated heart preparation could in¯uence vasorelaxation therefore it was important to establish if the differences were maintained in isolated precontracted aortae. Contraction dose-response curves to PE were not signi®cantly different between C57BL/6J and MF1 mouse aortic rings (maximum tension; 1.75 AE 0.23 and 1.31 AE 0.11 g/mg respectively). However, in line with the results seen in the whole heart, the endothelium-dependent agonist ACh produced a signi®cantly greater maximum relaxation in C57BL/6J aortic rings compared with MF1 rings (85 AE 9.6 and 57 AE 9.1% respectively, P , 0.05, Fig. 3(A) ). Relaxations to ACh were improved in the presence of Tiron in MF1 aortae but remained unchanged in C57BL/6J mice Figure 1 Coronary vascular relaxation to endotheliumdependent and -independent vasoactive agents. Percentage changes in CPP of isolated hearts from MF1 ( ), 129sv ( ) and C57BL/6J (&) mice in response to increasing doses of (A) bradykinin (1 nmol/L±0.1 mmol/L); (B) ACh (1 nmol/L±10 mmol/L); and (C) SNP (10 nmol/L± 0.1 mmol/L). * P , 0.05; ** P , 0.01; *** P , 0.001.
[ Fig. 3(B) ]. Maximal relaxation in response to the calcium ionophore A23187 and SNP was, however, similar between MF1 and C57BL/6J mice [Figs 3(C) and (D)].
Expression of eNOS and NADPH oxidase subunits
The level of eNOS protein expression was signi®-cantly reduced in C57BL/6J hearts when compared with the MF1 strain [P , 0.05, Figs 4(A) and (B) ].
Signi®cant differences were also seen in the expression level of 2 subunits of the NADPH oxidase complex, namely gp91 phox (a component of the membrane bound cytochrome b 558 , thought to be responsible for O À 2 generation) and p67 phox (a regulatory subunit). C57BL/6J hearts expressed signi®cantly reduced amounts of gp91 phox compared with MF1 and 129sv hearts [P , 0.05, Figs 4(A) and (B) ]. In addition, p67 phox protein expression was signi®cantly decreased in both C57BL/6J and 129sv hearts compared with the MF1 strain [P , 0.05, Figs 4(A) and (B) ].
NADPH-driven superoxide production
Consistent with the differences observed in NADPH oxidase subunit expression, NADPH-driven O scavenger, Tiron, but was unaffected by the NOS inhibitor, L-NAME in all three groups [ Fig. 5(B) ]. In line with these results, NADPH-driven O À 2 production was also signi®cantly increased in aortae from MF1 mice compared with C57BL/6J [ Fig. 5(C) ]. Again, DPI and Tiron abolished the chemiluminescence signal whereas L-NAME had no signi®cant effect (data not shown).
Discussion
The present study demonstrates that marked murine strain-dependent differences exist in terms of 17 This is one of the ®rst studies to investigate strain-dependent differences in coronary vascular tone in the isolated murine heart. Importantly, Chaitagneau et al. 18 demonstrated that endothelium-dependent relaxations to ACh in aortae and left descending coronary arteries of C57BL/ 6J mice were completely abolished by inhibition of NOS or by gene-targeted deletion of eNOS (eNOSde®cient mice), indicating that in these vessels NO is the main contributor to the response to ACh. However, in contrast, in the integrated coronary bed Godecke et al. 7, 19 demonstrated that, whilst responses to bradykinin are predominantly NOmediated, 19±20 responses to ACh have a signi®cant prostacyclin-dependent component. EDHF did not appear to contribute to coronary relaxation in response to these endothelium-dependent vasodilators.
In the present study, coronary vasodilator responses to both endothelium-dependent vasoactive agents, ACh and bradykinin, differed signi®-cantly between the strains with the MF1 hearts consistently responding poorly. Maximal coronary vasodilator responses to the endothelium-independent agonist, SNP also differed among the strains. However, the differences were less marked due mainly to improved relaxation in the MF1 hearts. These results suggest therefore that the observed differences in coronary vascular relaxation may re¯ect differences in both the endothelial response to the agonists and the coronary vascular response to NO per se. Differences in the response of the two inbred strains to ACh could also re¯ect differences in receptor density, the signal transduction pathway or the relative contributions of potential vasodilator agents other than NO, such as prostacyclins and EDHF. Interpretation of the data is however complicated by the fact that C57BL/6J isolated mouse hearts had a greater basal coronary vascular resistance compared with MF1 hearts, with 129sv hearts being at an intermediate value. Consistent with the lower basal resistance, the maximal response to adenosine (as an index of the maximal coronary dilator capacity) 21 was signi®cantly lower in MF1 hearts compared with the other two strains. The underlying causes of the variation in basal coronary vascular resistances in the isolated heart preparations were not studied. However, factors other than NO such as leukotrienes, thromboxane, endothelin and angiotensin II may play a role in increasing vascular tone in C57BL/6J mice.
In order to completely eliminate the confounding effects of coronary¯ow, basal vascular resistance and the absence of a preload in the isolated heart preparation and to compare relaxation between different vascular beds, aortic ring experiments were conducted. In line with the isolated heart data, vascular responses to the endothelium-dependent agonist, ACh, were signi®cantly greater in C57BL/ 6J rings compared with the MF1 strain. The O À 2 scavenger, Tiron, signi®cantly improved vascular relaxations in MF1 mice but had no effect in C57BL/6J animals. The observation that Tiron restored responses in the MF1 strain so that they resembled those obtained in C57BL/6J aortae suggests that the impaired responses in this strain may be due to increased scavenging of bioavailable NO by O À 2 . These data highlight the fact that, irrespective of vascular resistance, C57BL/6J vessels demonstrate a markedly increased response to endothelium-derived NO compared with the other strains. However, responses to the endotheliumdependent, receptor-independent NO agonist, A23187, and the endothelium-independent NO agonist, SNP, were not different. In the aorta, therefore, differences in vascular responsiveness and sensitivity may be due mainly to an increased inactivation of endothelial-derived NO by O À
.
The vascular response to NO is known to be in¯uenced by several factors, including the level of eNOS protein expression, the amount of NO released, inactivation of NO by reactive oxygen species, and vascular smooth muscle responsiveness per se. 22 Western blot analysis demonstrated paradoxically that, although C57BL/6J hearts were most sensitive to both ACh and bradykinin, eNOS protein expression was least in these hearts. On the other hand, basal NO bioactivity, as estimated by NO synthase inhibition, was highest in the C57BL/ 6J strain and lowest in the MF1 strain. These conicting data may be explained by the upregulation of other NOS isoforms in C57BL/6J mice. However, since NO-dependent vascular effects re¯ect the balance between NO production and inactivation, 23 we assessed NADPH oxidase expression and activity in these hearts. The phagocyte-type NADPH oxidase complex is now considered to be a major source of O À 2 in endothelium, vascular smooth muscle, adventitial ®broblasts and cardiac myocytes, 2, 24, 25 and several studies have now demonstrated that O À 2 generated from this oxidase in¯uences vascular tone both in vitro and in vivo.
26±28 Importantly, C57BL/6J hearts expressed lower protein levels of the NADPH oxidase subunits, gp91 phox and p67 phox , and MF1 hearts the highest. We also found that NADPH-dependent O À 2 generation in MF1 LV homogenate and aortae was signi®cantly higher than observed for C57BL/6J and 129sv strains. In line with the suggestion that the O À 2 generated in these tissues is derived from the NADPH oxidase, chemiluminescence was completely inhibited by the¯avoprotein inhibitor, DPI, but not by the NOS inhibitor, L-NAME. The fact that Tiron could restore ACh-induced vasorelaxation in MF1 aortae to that obtained in C57BL/6J animals suggests that such an upregulation of NADPH oxidase activity plays an important role in the control of vascular smooth muscle tone. However further experiments are required before this conclusion could be extended to the coronary vasculature.
In summary, this study demonstrates that there are marked strain-dependent differences in murine coronary vascular function and highlights the importance of characterizing baseline physiology prior to interpretation of potential differences induced by genetic manipulation. Differences in coronary vascular sensitivity to ACh, bradykinin and SNP and basal coronary vascular tone may re¯ect variations in the relative balance between NO and O À 2 production and degradation. Since a hallmark of many cardiovascular pathologies, including hypertension, hypertrophy and heart failure, is altered production of reactive oxygen species, baseline differences in these parameters will undoubtedly in¯uence the development of such pathologies in transgenic murine models of disease.
